1,658
Views
4
CrossRef citations to date
0
Altmetric
Research Paper

Selective inhibitors of trypanosomal uridylyl transferase RET1 establish druggability of RNA post-transcriptional modifications

, , , , , & show all
Pages 611-619 | Received 23 Oct 2015, Accepted 23 Dec 2015, Published online: 27 May 2016

References

  • Guan L, Disney MD. Recent advances in developing small molecules targeting RNA. ACS Chem Biol 2012; 7:73-86; PMID:22185671; http://dx.doi.org/10.1021/cb200447r
  • Esteller M. Non-coding RNAs in human disease. Nat Rev Genetics 2011; 12:861-74; PMID:22094949; http://dx.doi.org/10.1038/nrg3074
  • Schaefer M, Hagemann S, Hanna K, Lyko F. Azacytidine inhibits RNA methylation at DNMT2 target sites in human cancer cell lines. Cancer Res 2009; 69:8127-32; PMID:19808971; http://dx.doi.org/10.1158/0008-5472.CAN-09-0458
  • Sousa E, Graça I, Baptista T, Vieira FQ, Palmeira C, Henrique R, Jerónimo C. Enoxacin inhibits growth of prostate cancer cells and effectively restores microRNA processing. Epigenetics 2013; 8:548-58; PMID:23644875; http://dx.doi.org/10.4161/epi.24519
  • Ling H, Fabbri M, Calin GA. MicroRNAs and other non-coding RNAs as targets for anticancer drug development. Nat Rev Drug Discov 2013; 12:847-65; PMID:24172333; http://dx.doi.org/10.1038/nrd4140
  • Shen B, Goodman HM. Uridine addition after microRNA-directed cleavage. Science 2004; 306:997; PMID:15528436; http://dx.doi.org/10.1126/science.1103521
  • Norbury CJ. Cytoplasmic RNA: a case of the tail wagging the dog. Nat Rev Mol Cell Biol 2013; 14:643-53; PMID:23989958; http://dx.doi.org/10.1038/nrm3645
  • Yates LA, Fleurdépine S, Rissland OS, De Colibus L, Harlos K, Norbury CJ, Gilbert RJ. Structural basis for the activity of a cytoplasmic RNA terminal uridylyl transferase. Nat Struct Mol Biol 2012; 19:782-7; PMID:22751018; http://dx.doi.org/10.1038/nsmb.2329
  • Piskounova E, Polytarchou C, Thornton JE, LaPierre RJ, Pothoulakis C, Hagan JP, Iliopoulos D, Gregory RI. Lin28A and Lin28B inhibit let-7 microRNA biogenesis by distinct mechanisms. Cell 2011; 147:1066-79; PMID:22118463; http://dx.doi.org/10.1016/j.cell.2011.10.039
  • Heo I, Joo C, Kim YK, Ha M, Yoon MJ, Cho J, Yeom KH, Han J, Kim VN. TUT4 in concert with Lin28 suppresses microRNA biogenesis through pre-microRNA uridylation. Cell 2009; 138:696-708; PMID:19703396; http://dx.doi.org/10.1016/j.cell.2009.08.002
  • Lin S, Gregory RI. Identification of small molecule inhibitors of Zcchc11 TUTase activity. RNA Biol 2015; 12:792-800; PMID:26114892; http://dx.doi.org/10.1080/15476286.2015.1058478
  • Aphasizheva I, Aphasizhev R. RET1-catalyzed uridylylation shapes the mitochondrial transcriptome in Trypanosoma brucei. Mol Cell Biol 2010; 30:1555-67; PMID:20086102; http://dx.doi.org/10.1128/MCB.01281-09
  • Boutelle B, Oukem O, Bisser S, Dumas M. Treatment perspectives for human African trypanosomiasis. Fund Clin Pharmacol 2003; 17:171-81; PMID:12667227; http://dx.doi.org/10.1046/j.1472-8206.2003.00167.x
  • Aslett M, Aurrecoechea C, Berriman M, Brestelli J, Brunk BP, Carrington M, Depledge DP, Fischer S, Gajria B, Gao X, et al. TriTrypDB: a functional genomic resource for the Trypanosomatidae. NAR 2010; 38(Database issue):D457-62; PMID:19843604; http://dx.doi.org/10.1093/nar/gkp851
  • Alsford S, Turner DJ, Obado SO, Sanchez-Flores A, Glover L, Berriman M, Hertz-Fowler C, Horn D. High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome. Genome Res 2011; 21:915-24; PMID:21363968; http://dx.doi.org/10.1101/gr.115089.110
  • Thornton E, Chang HM, Piskounova E, Gregory RI. Lin28-mediated control of let-7 microRNA expression by alternative TUTases Zcchc11 (TUT4) and Zcchc6 (TUT7). RNA 2012; 10:1875-85; PMID:22898984; http://dx.doi.org/10.1261/rna.034538.112
  • Aphasizhev R, Aphasizheva I, Simpon L. A tale of two TUTases. Proc. Natl. Acad. Sci. USA 2003; 100:10617-22; PMID:12954983; http://dx.doi.org/10.1073/pnas.1833120100
  • Aphasizheva I, Aphasizhev R, Simpson L. RNA-editing Terminal Uridylyl Transferase 1. J Biol Chem 2004; 279:24123-30; PMID:15060068; http://dx.doi.org/10.1074/jbc.M401234200
  • Stasch JP, Pacher P, Evgenov OV. Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease. Circulation 2011; 123:2263-73; PMID:21606405; http://dx.doi.org/10.1161/CIRCULATIONAHA.110.981738
  • Allain H, Denmat J, Bentue-Ferrer D, Milon D, Pignol P, Reymann JM, Pape D, Sabouraud O, Van den Driessche J. Randomized, double-blind trial of exifone versus cognitive problems in Parkinson disease. Fundam Clin Pharmacol 1988; 2:1-12; PMID:3286439; http://dx.doi.org/10.1111/j.1472-8206.1988.tb00615.x
  • Winter RW, Ignatushchenko M, Ogundahunsi OA, Cornell KA, Oduola AM, Hinrichs DJ, Riscoe MK. Potentiation of an antimalarial oxidant drug. Antimicrob Agents Chemother 1997; 41:1449-54; PMID:9210664
  • Kahn SE, Haffner SM, Heise MA, Herman WH, Holman RR, Jones NP, Kravitz BG, Lachin JM, O'Neill MC, Zinman B, et al. ADOPT Study Group, Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. New Engl J Med 2006; 355:2427-43; PMID:17145742; http://dx.doi.org/10.1056/NEJMoa066224
  • Laws SC, Carey SA, Ferrell JM, Bodman GJ, Cooper RL. Estrogenic Activity of Octylphenol, Nonylphenol, Bisphenol A and Methoxychlor in Rats. Toxicol Sci 2000; 54:154-67; PMID:10746942; http://dx.doi.org/10.1093/toxsci/54.1.154
  • Ferno M, Borg A, Ingvar C, Jönsson PE. Estrogen receptor and binding site for estramustine in metastatic malignant melanoma. Anticancer Res 1987; 7:741-3; PMID:3314674
  • Hadjuk PJ, Gree J. A decade of fragment-based drug design: strategic advances and lessons learned. Nat Rev Drug Discov 2007; 6:211-9; PMID:17290284; http://dx.doi.org/10.1038/nrd2220
  • Krause G, Kroeger A. Topical treatment of American cutaneous leishmaniasis with paramomycin and methylbenzethonium chloride: a clinical study under field conditions in Ecuador. Trans R Soc Trop Med Hyg 1994; 88:92-4; PMID:8154018; http://dx.doi.org/10.1016/0035-9203(94)90517-7
  • Hertel C, Terzi E, Hauser N, Jakob-Rotne R, Seelig J, Kemp JA. Inhibition of the electrostatic interaction between β-amyloid peptide and membranes prevents β-amyloid-induced toxicity. Proc Natl Acad Sci USA 1997; 94:9412-6; PMID:9256496; http://dx.doi.org/10.1073/pnas.94.17.9412
  • Deng J, Ernst NL, Turley S, Stuart KD, Hol WG. Structural basis for UTP specificity of RNA editing TUTases from Trypanosoma brucei. EMBO 2005; 24:4007-17; PMID:16281058; http://dx.doi.org/10.1038/sj.emboj.7600861
  • Paramo T, East A, Garzon D, Ulmschneider MB, Bond PJ. Efficient Characterization of Protein Cavities within Molecular Simulation Trajectories: trj_cavity. J Chem Theory Comput 2014; 10:2151-64; PMID:26580540; http://dx.doi.org/10.1021/ct401098b
  • Lunde BM, Magler I, Meinhart A. Crystal structures of the Cid1 poly (U) polymerase reveal the mechanism for UTP selectivity. Nucleic Acids Res 2012; 40:9815-24; PMID:22885303; http://dx.doi.org/10.1093/nar/gks740